Biosimilar Avastin Is Launched In India
Cadila Pharmaceuticals Announces Entry
Executive Summary
Outlining plans to launch “multiple biosimilar products this year for the Indian market,” Cadila Pharmaceutical has just rolled out a biosimilar to Avastin (bevacizumab) in its domestic market.